Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
August 15, 2012
RELYPSA ANNOUNCES $80 MILLION PRIVATE FINANCING TRANSACTION
August 3, 2012
ATTEROCOR LAUNCHES INNOVATIVE COMPANY FOCUSED ON ACCELERATED DEVELOPMENT OF TREATMENT FOR ADRENAL CANCER; SECURES $16 MILLION SERIES A FINANCING
July 7, 2012
LUNDBECK HAS MADE EUR 10 MILLION EQUITY INVESTMENT IN BIOTIE AND THE PARTIES AMEND THE SELINCRO LICENSING AGREEMENT REGARDING TERRITORIES OUTSIDE THE EU AND US
July 5, 2012
BIOTIE COMPLETES ENROLLMENT IN PHASE 2B TRIAL OF TOZADENANT IN PARKINSON’S DISEASE
June 25, 2012
TELEFLEX ACQUIRES INNOVATIVE TECHNOLOGY TO REDUCE BIOLOGICAL FORMATION ON MEDICAL DEVICES
June 18, 2012
AMBRX COLLABORATES WITH MERCK TO DESIGN AND DEVELOP BIOLOGIC DRUG CONJUGATES
June 18, 2012
PATRICIA SCHELLER NAMED CEO OF VIVEVE, INC.
June 12, 2012
IGENICA CLOSES $33 MILLION IN SERIES C FUNDING
May 30, 2012
FLEXION’S LEAD OSTEOARTHRITIS DRUG CANDIDATE DEMONSTRATES SIGNIFICANT, PROLONGED IMPROVEMENT IN PAIN AND FUNCTION IN PHASE 2 TRIAL
May 28, 2012
THE VIVEVE SYSTEM RECEIVES HEALTH CANADA MEDICAL DEVICE LICENSE TO NON-SURGICALLY TREAT VAGINAL LAXITY FOLLOWING CHILDBIRTH
« Previous Page
1
…
107
108
109
110
111
…
119
Next Page »